← The Wire
GKOSNYSE
GLAUKOS Corp
Surgical & Medical Instruments & Apparatus · DE · CIK 1192448
Develops and commercializes novel ophthalmic therapies and medical technologies for eye diseases
$7.45B
Market cap
$142.19
Last close
-1.5%
1D
+8.4%
5D
1.2M
Volume
Price · last 39 sessions+4.7%
May 4L $103.12 · H $144.42Jun 29
245
Total filings
Jun 3, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 3, 20268-KReg FD DisclosureMay 4, 202610-Q10-QApr 30, 20268-KResults of Operations · Reg FD DisclosureApr 29, 2026DEFA14ADEFA14AApr 16, 2026DEF 14ADEF 14AApr 16, 20268-KReg FD DisclosureMar 2, 202610-K10-KFeb 23, 20268-KResults of Operations · Reg FD DisclosureFeb 17, 20268-KResults of Operations · Reg FD DisclosureJan 13, 20268-KReg FD DisclosureNov 10, 202510-Q10-QOct 31, 20258-KResults of Operations · Reg FD DisclosureOct 29, 20258-KReg FD DisclosureAug 12, 202510-Q10-QAug 4, 20258-KResults of Operations · Reg FD DisclosureJul 30, 20258-KShareholder VoteJun 3, 20258-KReg FD DisclosureMay 14, 202510-Q10-QMay 1, 20258-KResults of Operations · Reg FD DisclosureApr 30, 2025DEFA14ADEFA14AApr 15, 2025DEF 14ADEF 14AApr 15, 20258-KReg FD DisclosureMar 12, 202510-K10-KFeb 25, 20258-KResults of Operations · Reg FD DisclosureFeb 20, 20258-KReg FD DisclosureJan 14, 20258-KReg FD DisclosureDec 9, 20248-KMaterial AgreementDec 3, 20248-KReg FD DisclosureNov 15, 202410-Q10-QNov 5, 20248-KResults of Operations · Reg FD DisclosureNov 4, 20248-KCompany UpdateOct 11, 20248-KReg FD DisclosureAug 9, 20248-K/AResults of OperationsAug 2, 202410-Q10-QAug 2, 20248-KResults of Operations · Reg FD DisclosureJul 31, 20248-KEquity Issuance · Company UpdateJun 28, 20248-KEquity Issuance · Company UpdateJun 14, 20248-KExecutive Change · Shareholder VoteJun 5, 20248-KReg FD DisclosureMay 20, 202410-Q10-QMay 3, 20248-KResults of Operations · Reg FD DisclosureMay 1, 2024DEF 14ADEF 14AApr 16, 2024DEFA14ADEFA14AApr 16, 20248-KReg FD DisclosureFeb 28, 202410-K10-KFeb 23, 20248-KResults of Operations · Reg FD DisclosureFeb 21, 20248-KResults of Operations · Reg FD DisclosureJan 9, 20248-KReg FD DisclosureDec 14, 2023SC 13GSC 13GDec 11, 202310-Q10-QNov 1, 20238-KResults of Operations · Reg FD DisclosureNov 1, 20238-KReg FD DisclosureAug 18, 202310-Q10-QAug 2, 20238-KResults of Operations · Reg FD DisclosureAug 2, 20238-KShareholder VoteJun 7, 20238-KReg FD DisclosureMay 17, 202310-Q10-QMay 4, 20238-KResults of Operations · Reg FD DisclosureMay 3, 2023DEFA14ADEFA14AApr 18, 2023DEF 14ADEF 14AApr 18, 20238-KReg FD DisclosureMar 1, 202310-K10-KFeb 24, 20238-KResults of Operations · Reg FD DisclosureFeb 22, 2023SC 13GSC 13GJan 31, 20238-KReg FD DisclosureJan 10, 20238-KBylaw AmendmentDec 21, 20228-KReg FD DisclosureNov 15, 202210-Q10-QNov 4, 20228-KResults of Operations · Reg FD DisclosureNov 2, 20228-KReg FD DisclosureSep 7, 202210-Q10-QAug 5, 20228-KResults of Operations · Reg FD DisclosureAug 3, 20228-KShareholder VoteJun 8, 20228-KReg FD DisclosureMay 23, 202210-Q10-QMay 5, 20228-KResults of Operations · Reg FD DisclosureMay 4, 2022DEFA14ADEFA14AApr 19, 2022DEF 14ADEF 14AApr 19, 20228-KReg FD DisclosureMar 2, 2022
Insider Activity
In the 90 days to Mar 25, 2026: 6 sold $37.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 25, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 2,511 | $106.46 | $267K |
| Mar 24, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 1,521 | $105.24 | $160K |
| Mar 17, 2026 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER | Sell | 625 | $99.15 | $62K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 460 | $97.33 | $45K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 299 | $98.21 | $29K |
| Mar 16, 2026 | Navratil TomasCHIEF DEVELOPMENT OFFICER | Sell | 272 | $99.05 | $27K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 6,471 | $118.56 | $767K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 5,242 | $116.64 | $611K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 2,153 | $115.69 | $249K |
| Feb 19, 2026 | Weisner Aimee SDirector | Sell | 1,134 | $117.33 | $133K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 4,325 | $129.11 | $558K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 3,892 | $126.96 | $494K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 3,812 | $126.07 | $481K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 3,194 | $129.28 | $413K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 3,100 | $127.03 | $394K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 2,406 | $126.10 | $303K |
| Jan 22, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 1,798 | $128.07 | $230K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 1,671 | $127.92 | $214K |
| Jan 22, 2026 | Stapley MarcDirector | Sell | 1,300 | $129.78 | $169K |
| Jan 21, 2026 | Gilliam Joseph EPRESIDENT & COO | Sell | 4,502 | $124.65 | $561K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance